-
Something wrong with this record ?
ISL1 controls pancreatic alpha cell fate and beta cell maturation
R. Bohuslavova, V. Fabriciova, L. Lebrón-Mora, J. Malfatti, O. Smolik, L. Valihrach, S. Benesova, D. Zucha, Z. Berkova, F. Saudek, SM. Evans, G. Pavlinkova
Status not-indexed Language English Country England, Great Britain
Document type Journal Article
NLK
BioMedCentral
from 2011-01-01
BioMedCentral Open Access
from 2011
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2015-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-01-01
- Publication type
- Journal Article MeSH
BACKGROUND: Glucose homeostasis is dependent on functional pancreatic α and ß cells. The mechanisms underlying the generation and maturation of these endocrine cells remain unclear. RESULTS: We unravel the molecular mode of action of ISL1 in controlling α cell fate and the formation of functional ß cells in the pancreas. By combining transgenic mouse models, transcriptomic and epigenomic profiling, we uncover that elimination of Isl1 results in a diabetic phenotype with a complete loss of α cells, disrupted pancreatic islet architecture, downregulation of key ß-cell regulators and maturation markers of ß cells, and an enrichment in an intermediate endocrine progenitor transcriptomic profile. CONCLUSIONS: Mechanistically, apart from the altered transcriptome of pancreatic endocrine cells, Isl1 elimination results in altered silencing H3K27me3 histone modifications in the promoter regions of genes that are essential for endocrine cell differentiation. Our results thus show that ISL1 transcriptionally and epigenetically controls α cell fate competence, and ß cell maturation, suggesting that ISL1 is a critical component for generating functional α and ß cells.
Laboratory of Gene Expression Institute of Biotechnology CAS 25250 Vestec Czechia
Laboratory of Molecular Pathogenetics Institute of Biotechnology CAS 25250 Vestec Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23002710
- 003
- CZ-PrNML
- 005
- 20240624144032.0
- 007
- ta
- 008
- 230413s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13578-023-01003-9 $2 doi
- 035 __
- $a (PubMed)36899442
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bohuslavova, Romana $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia. romana.bohuslavova@ibt.cas.cz
- 245 10
- $a ISL1 controls pancreatic alpha cell fate and beta cell maturation / $c R. Bohuslavova, V. Fabriciova, L. Lebrón-Mora, J. Malfatti, O. Smolik, L. Valihrach, S. Benesova, D. Zucha, Z. Berkova, F. Saudek, SM. Evans, G. Pavlinkova
- 520 9_
- $a BACKGROUND: Glucose homeostasis is dependent on functional pancreatic α and ß cells. The mechanisms underlying the generation and maturation of these endocrine cells remain unclear. RESULTS: We unravel the molecular mode of action of ISL1 in controlling α cell fate and the formation of functional ß cells in the pancreas. By combining transgenic mouse models, transcriptomic and epigenomic profiling, we uncover that elimination of Isl1 results in a diabetic phenotype with a complete loss of α cells, disrupted pancreatic islet architecture, downregulation of key ß-cell regulators and maturation markers of ß cells, and an enrichment in an intermediate endocrine progenitor transcriptomic profile. CONCLUSIONS: Mechanistically, apart from the altered transcriptome of pancreatic endocrine cells, Isl1 elimination results in altered silencing H3K27me3 histone modifications in the promoter regions of genes that are essential for endocrine cell differentiation. Our results thus show that ISL1 transcriptionally and epigenetically controls α cell fate competence, and ß cell maturation, suggesting that ISL1 is a critical component for generating functional α and ß cells.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fabriciova, Valeria $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Lebrón-Mora, Laura $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Malfatti, Jessica $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Smolik, Ondrej $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Valihrach, Lukas $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Benesova, Sarka $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Zucha, Daniel $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
- 700 1_
- $a Berkova, Zuzana $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, 14021, Prague, Czechia
- 700 1_
- $a Saudek, Frantisek $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, 14021, Prague, Czechia
- 700 1_
- $a Evans, Sylvia M $u Department of Pharmacology; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA, USA
- 700 1_
- $a Pavlínková, Gabriela, $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia. gpavlinkova@ibt.cas.cz $1 https://orcid.org/0000000256896577 $d 1966- $7 xx0319150
- 773 0_
- $w MED00198696 $t Cell & bioscience $x 2045-3701 $g Roč. 13, č. 1 (2023), s. 53
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36899442 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20240624144030 $b ABA008
- 999 __
- $a ok $b bmc $g 1922637 $s 1188917
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 53 $e 20230310 $i 2045-3701 $m Cell & bioscience $n Cell Biosci $x MED00198696
- LZP __
- $a Pubmed-20230413